PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-40.37%
Negative revenue growth while 0455.HK stands at 100.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
4.11%
Gross profit growth under 50% of 0455.HK's 100.00%. Michael Burry would be concerned about a severe competitive disadvantage.
No Data
No Data available this quarter, please select a different quarter.
331.61%
Operating income growth above 1.5x 0455.HK's 100.00%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
122.84%
Net income growth 1.25-1.5x 0455.HK's 100.00%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
123.08%
EPS growth 1.25-1.5x 0455.HK's 100.00%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
123.08%
Diluted EPS growth 1.25-1.5x 0455.HK's 100.00%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
-1.87%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.87%
Reduced diluted shares while 0455.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-52.62%
Negative OCF growth while 0455.HK is at 130.63%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-52.45%
Negative FCF growth while 0455.HK is at 143.88%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-28.92%
Negative 10Y revenue/share CAGR while 0455.HK stands at 1174.07%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-28.39%
Negative 5Y CAGR while 0455.HK stands at 272.04%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
5.64%
3Y revenue/share CAGR under 50% of 0455.HK's 370.81%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
782.75%
10Y OCF/share CAGR above 1.5x 0455.HK's 152.27%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
157.26%
5Y OCF/share CAGR above 1.5x 0455.HK's 16.68%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
104.13%
3Y OCF/share CAGR at 50-75% of 0455.HK's 153.92%. Martin Whitman would suspect weaker recent execution or product competitiveness.
-68.71%
Negative 10Y net income/share CAGR while 0455.HK is at 103.85%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-46.68%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-57.80%
Negative 3Y CAGR while 0455.HK is 62.48%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
6.34%
Positive 5Y equity/share CAGR while 0455.HK is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-4.80%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 0455.HK stands at 522.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while 0455.HK invests at 448.79%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-37.69%
Firm’s AR is declining while 0455.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-50.48%
Inventory is declining while 0455.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-41.20%
Negative asset growth while 0455.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.14%
Positive BV/share change while 0455.HK is negative. John Neff sees a clear edge over a competitor losing equity.
-70.86%
We’re deleveraging while 0455.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-33.26%
We cut SG&A while 0455.HK invests at 100.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.